1. Home
  2. UPB vs CRAI Comparison

UPB vs CRAI Comparison

Compare UPB & CRAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UPB
  • CRAI
  • Stock Information
  • Founded
  • UPB 2021
  • CRAI 1965
  • Country
  • UPB United States
  • CRAI United States
  • Employees
  • UPB N/A
  • CRAI N/A
  • Industry
  • UPB
  • CRAI Other Consumer Services
  • Sector
  • UPB
  • CRAI Consumer Discretionary
  • Exchange
  • UPB NYSE
  • CRAI Nasdaq
  • Market Cap
  • UPB 1.3B
  • CRAI 1.2B
  • IPO Year
  • UPB 2024
  • CRAI 1998
  • Fundamental
  • Price
  • UPB $17.80
  • CRAI $189.38
  • Analyst Decision
  • UPB Strong Buy
  • CRAI Buy
  • Analyst Count
  • UPB 4
  • CRAI 1
  • Target Price
  • UPB $56.50
  • CRAI $212.00
  • AVG Volume (30 Days)
  • UPB 252.2K
  • CRAI 33.6K
  • Earning Date
  • UPB 11-07-2024
  • CRAI 10-31-2024
  • Dividend Yield
  • UPB N/A
  • CRAI 1.03%
  • EPS Growth
  • UPB N/A
  • CRAI 24.54
  • EPS
  • UPB N/A
  • CRAI 6.18
  • Revenue
  • UPB $2,207,000.00
  • CRAI $672,592,000.00
  • Revenue This Year
  • UPB N/A
  • CRAI $10.95
  • Revenue Next Year
  • UPB N/A
  • CRAI $2.76
  • P/E Ratio
  • UPB N/A
  • CRAI $30.62
  • Revenue Growth
  • UPB 82.10
  • CRAI 10.74
  • 52 Week Low
  • UPB $17.09
  • CRAI $92.07
  • 52 Week High
  • UPB $29.46
  • CRAI $208.38
  • Technical
  • Relative Strength Index (RSI)
  • UPB N/A
  • CRAI 48.78
  • Support Level
  • UPB N/A
  • CRAI $184.20
  • Resistance Level
  • UPB N/A
  • CRAI $207.76
  • Average True Range (ATR)
  • UPB 0.00
  • CRAI 6.06
  • MACD
  • UPB 0.00
  • CRAI -1.48
  • Stochastic Oscillator
  • UPB 0.00
  • CRAI 21.42

About UPB UPSTREAM BIO INC

Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin (TSLP), a cytokine which is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune mediated diseases.

About CRAI CRA International Inc.

CRA International Inc is a U.S.-based advisory firm that provides economic, financial, and management consultancy services. The company advises clients on economic and financial issues relating to litigation and regulatory proceedings and helps businesses set important business strategies and solve performance-related issues. The company's clients include domestic and foreign companies, government agencies, public and private utilities, and national and international trade associations. CRA International generates majority of its revenue from the United States.

Share on Social Networks: